Tau-based therapeutic approaches for Alzheimer's disease-a mini-review

A Boutajangout, T Wisniewski - Gerontology, 2014 - karger.com
The accumulation of aggregated, hyperphosphorylated tau as neurofibrillary tangles and
neuropil threads are cardinal features of Alzheimer's disease (AD). The other lesions found in …

Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain

A Boutajangout, J Ingadottir, P Davies… - Journal of …, 2011 - Wiley Online Library
Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces
functional decline and clears tau aggregates from the brain - Boutajangout - 2011 - Journal …

Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements

AA Asuni, A Boutajangout, D Quartermain… - Journal of …, 2007 - Soc Neuroscience
Immunotherapies for various neurodegenerative diseases have recently emerged as a
promising approach for clearing pathological protein conformers in these disorders. This type of …

Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model

A Boutajangout, D Quartermain… - Journal of …, 2010 - Soc Neuroscience
Harnessing the immune system to clear protein aggregates is emerging as a promising
approach to treat various neurodegenerative diseases. In Alzheimer's disease (AD), several …

Tau as a therapeutic target for Alzheimer's disease

A Boutajangout, EM Sigurdsson… - Current Alzheimer …, 2011 - ingentaconnect.com
Neurofibrillary tangles (NFTs) are one of the pathological hallmarks of Alzheimer's disease (AD)
and are primarily composed of aggregates of hyperphosphorylated forms of the …

Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology

…, RJ Kascsak, KA Bates, A Boutajangout… - Journal of …, 2009 - Soc Neuroscience
The pathogenesis of Alzheimer's disease (AD) is thought to be related to the accumulation
of amyloid β (Aβ) in amyloid deposits and toxic oligomeric species. Immunomodulation is …

[HTML][HTML] The innate immune system in Alzheimer's disease

A Boutajangout, T Wisniewski - International journal of cell biology, 2013 - hindawi.com
Alzheimer’s disease (AD) is the leading cause for dementia in the world. It is characterized
by two biochemically distinct types of protein aggregates: amyloid β (Aβ) peptide in the forms …

The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

K Leroy, A Boutajangout, M Authelet, JR Woodgett… - Acta …, 2002 - Springer
Glycogen synthase kinase-3β (GSK-3β) is a physiological kinase for tau and is a candidate
protein kinase involved in the hyperphosphorylation of tau present in paired helical filament (…

Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive …

JA Frontera, A Boutajangout, AV Masurkar… - Alzheimer's & …, 2022 - Wiley Online Library
… A Boutajangout has received support from the Amylon Therapeutic Company and a grant
from the Saudi Arabia Cultural … Boutajangout hold patents unrelated to this manuscript. Dr. R. …

[HTML][HTML] Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging

…, DM Hoang, Y Sun, H Xu, W Tsui, Y Li, A Boutajangout… - PloS one, 2013 - journals.plos.org
Amyloid plaques are a key pathological hallmark of Alzheimer’s disease (AD). The detection
of amyloid plaques in the brain is important for the diagnosis of AD, as well as for following …